Lantis – StockGuru Profile Lantis – OTC: LSSR.PK

Lantis Laser Inc. has the exclusive right to commercialize the application of OCT in the dental field, under its license Agreements with Lawrence Livermore National Laboratory and LightLab Imaging. Optical coherence tomography (OCT) is an example of a “state of the art” optoelectronics with a real-world applications. OCT utilizes photonics and fiber optics and therefore does not emit any harmful radiation.

OCT is a product of research in the area of physics. OCT is used in medical imaging equipment to see and understand the human body in order to better diagnose and treat diseases. Optical coherence tomography (OCT) is a medical imaging technology for non-invasive, high-resolution cross-sectional imaging used in many medical fields.

OCT serves as an optical biopsy, enabling tissue pathology to be imaged in suit and in real time. This technology provides a means for nondestructive evaluation of materials supported by optical data storage. OCT integrates a wide range of disciplines including fiber optics, interferometry, high speed optical detection, biomedical imaging, in vitro and in vivo studies, and clinical medicine.

There has been a dramatical increase in the imaging rate of OCT since its introduction.

Worldwide OCT Applications

OCT has become the prominent biomedical tissue imaging technique.

Ophthalmology is, due to the transparent ocular structures, still the main field of OCT application. The first commercial instrument too has been introduced for ophthalmic diagnostics (Carl Zeiss Meditec AG). Cardiology and dermatology employ OCT.

Even museums are using OCT directly on paintings to examine the cross-section of paint and varnish layers without contact or the need to take samples from anywhere on a painting. This allows them to evaluate the need and extent of restoration. Optical coherence tomography is a powerful non-invasive technique for probing into the depth of paintings, providing 3D infrared image cubes that can not only show the structure of the paint and varnish layers, but also reveal the underdrawings and their depth positions. This method allows cross-section examination over the entire painting. We are now extending our studies to quantitative measurements of the refractive index of varnish layers as well as studying the drying process of varnish.

Optical in vivo biopsy is a rapidly advancing field of OCT application. High resolution, high penetration depth, and its potential for functional imaging attribute to OCT an optical biopsy quality, which can be used to assess tissue and cell function and morphology in situ. OCT can already clarify the relevant architectural tissue morphology.

For many diseases, however, including cancer in its early stages, higher resolution is necessary. New broad-bandwidth light sources, like photonic crystal fibres and superfluorescent fibre sources, and new contrasting techniques, give access to new sample properties and unmatched sensitivity and resolution.

OCT Technology is highly regarded and being applied in many fields. Lantis Laser has the exclusive right to commercialize the application of OCT in the dental field.

Source: Lantis Laser Inc.

Contact: Lantis Laser Inc.
Stan Baron,President and CEO
11 Stonebridge Court
Denville, NJ 07834
Tel: (203) 300-7622

Forward-Looking Statements: Certain statements in this press release, including statements regarding the anticipated development and expansion of Lantis’ business, and the intent, belief or current expectations of Lantis, its directors or its officers, are forward-looking statements. Because such statements are subject to risks and uncertainties, actual results may differ materially from those expressed or implied by such forward-looking statement

Disclosure: Pentony Enterprises LLC was compensated $15,000 directly from the company and 55,000 free trading shares from a non controlling third party for profile coverage. Pentony Enterprises LLC is not a registered investment adviser or broker/dealer. Pentony Enterprises LLC makes no recommendation that the purchase of securities of companies profiled in this web site is suitable or advisable for any person or that an investment in such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market for their securities, investing in such securities is highly speculative and carries a high degree of risk. It is the policy of Pentony Enterprises LLC to sell all shares of this and any company featured. Anyone considering any company we feature in consideration for free trading shares should consider this.
StockGuru.com is owned and operated by Pentony Enterprises LLC, 9555 Lebanon Road, Suite 103, Frisco, Texas 75035. Telephone: (214) 458-4258. Web: StockGuru.com. Email: Publisher@stockguru.com .